Betagenex is a preclinical Contract Research Organization (CRO) providing scientific expertise and drug discovery services in metabolic diseases to the pharmaceutical and biotech industries.

Based on our internationally recognized expertise in diabetes, obesity, and pancreatic beta-cell function, we offer a complete array of preclinical services for compound testing and target validation using state-of-the-art approaches and experimental models.

Research Capabilities


  • Assessment of B-cell function
  • In vivo metabolic phenotyping
  • Surgical and pharmacological animal models